High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China

BACKGROUND: The effective treatment of coronavirus disease 2019 (COVID-19) remains unclear. We reported successful use of high-dose intravenous immunoglobulin (IVIg) in cases of severe COVID-19, but evidence from larger case series is still lacking. METHODS: A multi-center retrospective study was co...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Immunol
Autori principali: Cao, Wei, Liu, Xiaosheng, Hong, Ke, Ma, Zhiyong, Zhang, Yuelun, Lin, Ling, Han, Yang, Xiong, Yong, Liu, Zhengyin, Ruan, Lianguo, Li, Taisheng
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Immunology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7933558/
https://ncbi.nlm.nih.gov/pubmed/33679771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.627844
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi